bioRxivNeurosciencePreprint
Impaired neurogenesis and synaptogenesis in iPSC-derived Parkinson's patient cortical neurons with D620N VPS35 mutation
Ute Scheller, ChoongKu Lee, Philip SeibleriD, Mišo MitkovskiiD, JeongSeop RheeiD, Christoph van RieseniD
Abstract
Presynaptic dysfunction is an important early process in the pathophysiology of Parkinsons disease (PD) that drives disease progression. To gain insight into the intrinsic synapse impairment in PD, we performed comprehensive electrophysiological and morphological analysis of iPSC-derived cortical neurons derived from PD patients with the VPS35-D620N mutation. Our findings reveal significant impairment in neurogenesis and synaptogenesis within individual patient neurons, culminating to synaptic dysfunction even in the absence of neuronal interactions. The neurons exhibited significantly reduced synaptic responsiveness, fewer synapse and decreased dendritic length and complexity. Thus, the VPS35-D620N mutation in human cortical neurons independently can cause pathophysiology via synaptic dysfunction. Our study highlights the urgent need to develop disease-modifying therapies aimed at preserving synaptic function in PD.
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced synaptic activity and dysregulated extracellular matrix pathways are common phenotypes in midbrain neurons derived from sporadic and mutation-associated Parkinson's disease patients
Shani Stern, Shong Lau, … Fred H. Gage·bioRxiv·Dec 31, 2021
- iPSC-derived extracellular vesicles rescue deficits in human and mouse models of Parkinsons disease
Wote Amelo Rike, Utkarsh Tripathi, … Shani Stern·bioRxiv·May 26, 2026
- Upregulated extracellular matrix-related genes and impaired synaptic activity in dopaminergic and hippocampal neurons derived from Parkinson's disease patients with PINK1 and PARK2 mutations
Utkarsh Tripathi, Idan Rosh, … Shani Stern·bioRxiv·Dec 9, 2022
- VPS35 and α-Synuclein Fail to Interact to Modulate Neurodegeneration in Rodent Models of Parkinson's Disease
Xi Chen, Elpida Tsika, … Darren J. Moore·Molecular NeurodegenerationPeer-reviewed·Aug 4, 2023
- Dopamine and cortical iPSC-derived neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction: implications for protein deposition versus selective cell loss
Jessica Chedid, Yan Li, … Nicolas L. Dzamko·npj Parkinson s DiseasePeer-reviewed·Jun 20, 2025
- Gene-corrected Parkinson's disease neurons show the A30P alpha-synuclein point mutation leads to reduced neuronal branching and function
Peter A. Barbuti, Bruno F. R. Santos, … Rejko Krüger·bioRxiv·Nov 5, 2020